These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

609 related articles for article (PubMed ID: 21659570)

  • 1. Evolution of the TIR domain-containing adaptors in humans: swinging between constraint and adaptation.
    Fornarino S; Laval G; Barreiro LB; Manry J; Vasseur E; Quintana-Murci L
    Mol Biol Evol; 2011 Nov; 28(11):3087-97. PubMed ID: 21659570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.
    McGettrick AF; O'Neill LA
    Mol Immunol; 2004 Jul; 41(6-7):577-82. PubMed ID: 15219996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIR-containing adaptors in Toll-like receptor signalling.
    Jenkins KA; Mansell A
    Cytokine; 2010 Mar; 49(3):237-44. PubMed ID: 19264502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARM modulates MyD88-mediated TLR activation through BB-loop dependent TIR-TIR interactions.
    Carlsson E; Ding JL; Byrne B
    Biochim Biophys Acta; 2016 Feb; 1863(2):244-53. PubMed ID: 26592460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.
    O'Neill LA; Bowie AG
    Nat Rev Immunol; 2007 May; 7(5):353-64. PubMed ID: 17457343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Signalling adaptors used by Toll-like receptors: an update.
    Kenny EF; O'Neill LA
    Cytokine; 2008 Sep; 43(3):342-9. PubMed ID: 18706831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative and phylogenetic analyses of three TIR domain-containing adaptors in metazoans: implications for evolution of TLR signaling pathways.
    Wu B; Xin B; Jin M; Wei T; Bai Z
    Dev Comp Immunol; 2011 Jul; 35(7):764-73. PubMed ID: 21362440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of four TIR domain-containing adaptors, MyD88, TRIF, MAL, and SARM in mandarin fish Siniperca chuatsi.
    Wang KL; Chen SN; Li L; Huo HJ; Nie P
    Dev Comp Immunol; 2021 Sep; 122():104110. PubMed ID: 33933533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specificity in Toll-like receptor signalling through distinct effector functions of TRAF3 and TRAF6.
    Häcker H; Redecke V; Blagoev B; Kratchmarova I; Hsu LC; Wang GG; Kamps MP; Raz E; Wagner H; Häcker G; Mann M; Karin M
    Nature; 2006 Jan; 439(7073):204-7. PubMed ID: 16306937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular analysis of the binding mode of Toll/interleukin-1 receptor (TIR) domain proteins during TLR2 signaling.
    Nada M; Ohnishi H; Tochio H; Kato Z; Kimura T; Kubota K; Yamamoto T; Kamatari YO; Tsutsumi N; Shirakawa M; Kondo N
    Mol Immunol; 2012 Oct; 52(3-4):108-16. PubMed ID: 22673208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Troll in Toll: Mal and Tram as bridges for TLR2 and TLR4 signaling.
    Sheedy FJ; O'Neill LA
    J Leukoc Biol; 2007 Aug; 82(2):196-203. PubMed ID: 17449723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [TIR domain--containing adaptors regulate TLR-mediated signaling pathways].
    Yamamoto M; Akira S
    Nihon Rinsho; 2004 Dec; 62(12):2197-203. PubMed ID: 15597785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
    Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
    Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARM inhibits both TRIF- and MyD88-mediated AP-1 activation.
    Peng J; Yuan Q; Lin B; Panneerselvam P; Wang X; Luan XL; Lim SK; Leung BP; Ho B; Ding JL
    Eur J Immunol; 2010 Jun; 40(6):1738-47. PubMed ID: 20306472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Viral inhibitory peptide of TLR4, a peptide derived from vaccinia protein A46, specifically inhibits TLR4 by directly targeting MyD88 adaptor-like and TRIF-related adaptor molecule.
    Lysakova-Devine T; Keogh B; Harrington B; Nagpal K; Halle A; Golenbock DT; Monie T; Bowie AG
    J Immunol; 2010 Oct; 185(7):4261-71. PubMed ID: 20802145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mal (MyD88-adapter-like) is required for Toll-like receptor-4 signal transduction.
    Fitzgerald KA; Palsson-McDermott EM; Bowie AG; Jefferies CA; Mansell AS; Brady G; Brint E; Dunne A; Gray P; Harte MT; McMurray D; Smith DE; Sims JE; Bird TA; O'Neill LA
    Nature; 2001 Sep; 413(6851):78-83. PubMed ID: 11544529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Toll-IL-1 receptor adaptor family grows to five members.
    O'Neill LA; Fitzgerald KA; Bowie AG
    Trends Immunol; 2003 Jun; 24(6):286-90. PubMed ID: 12810098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.
    Hardy MP; McGGettrick AF; O'Neill LA
    Biochem J; 2004 May; 380(Pt 1):83-93. PubMed ID: 14960149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.